Pascal Biosciences
  • Company
    • About
    • Leadership
    • Board of Directors
  • Programs
    • Overview
    • PAS-403 for Glioblastoma
    • PAS-393 for Cancer
    • Research: Pre-BCR antibody for Leukemia
  • News
  • Investors
  • Contact
Skip to content

10Nov 2018

Pascal Biosciences CEO interview on Canada Pot Talks 107.7 Pulse FM (minute 46)

  • Nov 10, 2018
  • In the News

Listen to an interview with CEO Patrick Gray on Canada Pot Talks. Canada Pot Talks - November 10th 2018

Read More

8Nov 2018

CFN's exclusive Interview with Pascal Biosciences

  • Nov 8, 2018
  • In the News

CEO Patrick Gray sat down with CFN Media for an exclusive interview. Read the full interview here.  

Read More

Recent Posts

  • Pascal Biosciences Commences Cannabinoid Testing of Human Volunteers and Patients
  • Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
  • Pascal Biosciences Announces Year-End Investor Update Webcast
  • Pascal Biosciences Expands Leadership Team to Support Strategic Advancement of Its Cannabinoid Based Programs
  • Pascal Biosciences CEO interview on Canada Pot Talks 107.7 Pulse FM (minute 46)

Categories

  • In the News
  • Press Releases

Archives

  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • July 2018
  • June 2018
  • February 2018
  • December 2017
  • September 2017
  • May 2017
  • March 2017
  • November 2016
  • October 2016
  • September 2016

About

Pascal Biosciences Inc. (TSX-V: PAS) is a biotechnology company focused on developing cannabinoid-based and targeted therapeutics to fight cancer.

Locations

USA

Fluke Hall, Suite 304
Box 352141
4000 Mason Road
Seattle, WA 98195-2141

Canada

280 7th Avenue East
Vancouver, BC V5T 0B4

Contact

Phone

206.221.3443

Email

info@pascalbiosciences.com

Investors

invest@pascalbiosciences.com

Partnering & Business Development

bd@pascalbiosciences.com

Let's Connect

  • Twitter
  • Linked
  • Home
  • Company
  • Programs
  • News
  • Investors
  • Contact
  • Disclaimer

© Copyright 2019 Pascal Biosciences Inc. All rights reserved.   Seattle Website Design by Jordan Crown Design

  • Company
    • About
    • Leadership
    • Board of Directors
  • Programs
    • Overview
    • PAS-403 for Glioblastoma
    • PAS-393 for Cancer
    • Research: Pre-BCR antibody for Leukemia
  • News
  • Investors
  • Contact

‹ › ×